Taperloc Complete

The Taperloc Complete is specifically designed for cementless hip arthroplasty, meaning it is intended for use in total hip replacements where the acetabular component is implanted without bone cement. Unlike cemented alternatives, this device relies on osseointegration—the direct bonding of bone to the metal surface—to achieve stable fixation. This approach is often preferred for patients with healthy bone quality or those seeking long-term durability without the risks associated with cement, such as loosening or allergic reactions.

The Taperloc Complete is reusable, meaning it is intended for multiple surgical uses within a sterile operating environment. However, proper sterilization and handling protocols must be followed between cases to ensure safety and functionality. It is critical to adhere to Biomet’s sterilization guidelines (e.g., autoclave or ethylene oxide) and avoid contamination to maintain its structural integrity and biocompatibility for subsequent procedures.

The Taperloc Complete comes in multiple variants, as indicated by the extensive list of FEI numbers (e.g., 3020282716, 1000116912) and registration numbers, which correspond to specific acetabular component sizes, diameters, and orientations. Selection depends on factors like patient anatomy, bone morphology, and surgical approach. Orthopedic surgeons typically use preoperative imaging (e.g., CT or X-rays) and sizing tools provided by Biomet to match the patient’s acetabulum dimensions to the appropriate component for optimal fit and stability.

Since the Taperloc Complete is reusable, it must be stored in a clean, dry, and sterile environment when not in use. Biomet’s packaging and storage instructions (not explicitly detailed here but implied by its reusable classification) likely include protective cases or pouches to prevent contamination. If sterilized via autoclave or ethylene oxide, it should be stored according to the manufacturer’s guidelines to avoid degradation of materials or compromise of sterility until the next surgical use.

The Taperloc Complete received FDA 510(k) clearance under the Traditional pathway (K101086), meaning Biomet demonstrated that it is substantially equivalent to a legally marketed predicate device (a previously cleared hip prosthesis) in terms of technology, performance, and safety. This pathway ensures the device meets FDA standards for orthopedic implants (21 CFR 888.3330) and has undergone rigorous testing for biocompatibility, structural integrity, and clinical performance before approval.